Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?

Key findings include a higher incidence in females (65%) and older average age at presentation than Crohn's disease at other sites, a mucosa-associated microbiota between that found in ileal Crohn’s disease and UC, and no response to mesalazine, but possibly better response to antitumour necrosis factor.